Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 4
2009 4
2010 9
2011 10
2012 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer.
Gao W, Xu J, Liu L, Shen H, Zeng H, Shu Y. Gao W, et al. Biomed Pharmacother. 2012 Feb;66(1):21-8. doi: 10.1016/j.biopha.2011.09.004. Epub 2011 Dec 28. Biomed Pharmacother. 2012. PMID: 22244963 Review.
Characterization of the Melanoma miRNAome by Deep Sequencing.
Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK. Stark MS, et al. PLoS One. 2010 Mar 12;5(3):e9685. doi: 10.1371/journal.pone.0009685. PLoS One. 2010. PMID: 20300190 Free PMC article.
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
Visone R, Veronese A, Balatti V, Croce CM. Visone R, et al. Oncotarget. 2012 Feb;3(2):195-202. doi: 10.18632/oncotarget.448. Oncotarget. 2012. PMID: 22350310 Free PMC article.
MicroRNAs associated with metastatic prostate cancer.
Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y. Watahiki A, et al. PLoS One. 2011;6(9):e24950. doi: 10.1371/journal.pone.0024950. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21980368 Free PMC article.
MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.
Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M, Carinci F. Scapoli L, et al. Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1229-34. doi: 10.1177/039463201002300427. Int J Immunopathol Pharmacol. 2010. PMID: 21244772 Free article.
miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE. Kim CH, et al. BMC Med Genomics. 2011 Nov 23;4:79. doi: 10.1186/1755-8794-4-79. BMC Med Genomics. 2011. PMID: 22112324 Free PMC article.
miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.
Vaira V, Faversani A, Dohi T, Montorsi M, Augello C, Gatti S, Coggi G, Altieri DC, Bosari S. Vaira V, et al. Oncogene. 2012 Jan 5;31(1):27-38. doi: 10.1038/onc.2011.209. Epub 2011 Jun 6. Oncogene. 2012. PMID: 21643016 Free PMC article.
Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma.
Ma WJ, Lv GD, Tuersun A, Liu Q, Liu H, Zheng ST, Huang CG, Feng JG, Wang X, Lin RY, Sheyhidin I, Lu XM. Ma WJ, et al. Mol Biol Rep. 2011 Jun;38(5):3253-60. doi: 10.1007/s11033-010-0480-9. Epub 2010 Nov 20. Mol Biol Rep. 2011. PMID: 21104017
Smad3-mediated upregulation of miR-21 promotes renal fibrosis.
Zhong X, Chung AC, Chen HY, Meng XM, Lan HY. Zhong X, et al. J Am Soc Nephrol. 2011 Sep;22(9):1668-81. doi: 10.1681/ASN.2010111168. Epub 2011 Aug 18. J Am Soc Nephrol. 2011. PMID: 21852586 Free PMC article.
Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study.
Bansal A, Lee IH, Hong X, Anand V, Mathur SC, Gaddam S, Rastogi A, Wani SB, Gupta N, Visvanathan M, Sharma P, Christenson LK. Bansal A, et al. Am J Gastroenterol. 2011 Jun;106(6):1055-63. doi: 10.1038/ajg.2011.37. Epub 2011 Mar 15. Am J Gastroenterol. 2011. PMID: 21407181 Clinical Trial.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page